A prospective study on the efficacy of mometasone furoate monohydrate aqueous nasal spray on Chinese patients with allergic rhinitis

Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 4, 2003, Pages 497-502

  Tsang, Raymond K Y ^b   Tong, Michael C F ^b   Woo, John K S ^b   Van Hasselt, C Andrew ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MOMETASONE FUROATE; NOSE SPRAY;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; AQUEOUS SOLUTION; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEMOGRAPHY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TOLERABILITY; ENDOSCOPY; EPISTAXIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE AIRFLOW; NOSE CAVITY; NOSE IRRITATION; NOSE MUCOSA; NOSE OBSTRUCTION; OPEN STUDY; PHARYNGITIS; QUESTIONNAIRE; RHINORRHEA; SCORING SYSTEM; SIDE EFFECT; SNEEZING; TREATMENT OUTCOME;

EID: 0347298739     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(02)23242-8     Document Type: Article

References (15)

1. Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. BMJ 1987;294:279-83.
2. Lau YL, Karlberg J. Prevalence and risk factors of childhood asthma, rhinitis and eczema in Hong Kong. J Paediatr Child Health 1998;34(1):47-52.
3. Prakash A, Benfield P. Topical mometasone: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs 1998;55:145-63.
4. Herbert JR, Nolop K, et al. Once-daily mometasone furoate aqueous nasal spray (Nasonex™) nasal spray in seasonal allergic rhinitis: an active and placebo-controlled study. Allergy 1996;51:569-76.
5. Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group. Ann Allergy Asthma Immunol 1997;79:237-45, 370-8.
6. Schenkel EJ, Nolop K. Evaluation of mometasone furoate (Nasonex™) nasal spray with addition of loratadine vs placebo in the treatment of seasonal allergic rhinitis [abstract]. Presented at the Annual Meeting of the American College of Allergy, Asthma & Immunology, 1996.
7. Lebel B, Bousquet J, Morel A, et al. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 1988;5:869-77.
8. Lund VJ, Kennedy DW. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol (Suppl) 1995;167(Suppl):17-21.
9. International Rhinitis Management Group. International consensus on the management of rhinitis. Clin Immunother 1995;4:270-8.
10. Frolund L. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol 1991;16:527-31.
11. Bronsky EA, Aaronson DW, Berkowitz RB, et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:51-6.
12. Berkowitz RB, Bernstein DI, Laforce C, et al. Onset of action of mometasone furoate nasal spray (MFNS) in seasonal allergic rhinitis (SAR). Allergy 1999;54:890.
13. Schering-Plough Research Institute. SCH 32088: Single-dose absolute bioavailability study of mometasone furoate administered as an intravenous solution, oral solution, oral suspension and nasal spray - a four-way crossover design. Study no. C95-050-01 (Data on file). Kenilworth, NJ, Schering-Plough Corp.
14. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000;105: e22.
15. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:e23.